{"prompt": "['PREDM', 'Page 51', '19.', \"Derosa G, D'Angelo A, Romano D, et al: Effects of metformin extended release\", 'compared to immediate release formula on glycemic control and glycemic variability in', 'patients with type 2 diabetes. Drug Des Devel Ther 11:1481-1488, 2017', '20.', 'Crowley MJ, Diamantidis CJ, McDuffie JR, et al: Clinical outcomes of metformin', 'use in populations with chronic kidney disease, congestive heart failure, or chronic liver', 'disease: a systematic review. Ann Intern Med 166:191-200, 2017', '21.', 'Bodmer M, Meier C, Kr\u00e4henb\u00fchl S, et al: Metformin, sulfonylureas, or other', 'antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control', 'analysis. Diabetes care 31:2086-2091, 2008', '22.', 'Misbin RI, Green L, Stadel BV, et al: Lactic Acidosis in Patients with Diabetes', 'Treated with Metformin. New England Journal of Medicine 338:265-266, 1998', '23.', 'Stang M, Wysowski DK, Butler-Jones D: Incidence of lactic acidosis in metformin', 'users. Diabetes Care 22:925-927, 1999', '24.', 'Hostalek U, Gwilt M, Hildemann S: Therapeutic use of metformin in prediabetes', 'and diabetes prevention. Drugs 75:1071-1094, 2015', '25.', 'Moin T, Schmittdiel JA, Flory JH, et al: Review of metformin use for type 2', 'diabetes prevention. Am J Prev Med 55:565-574, 2018', '26.', 'Jacobs S, Radnitz C, Hildebrandt T: Adherence as a predictor of weight loss in a', 'commonly used smartphone application. Obes Res Clin Pract 11:206-214, 2017', '27.', 'Chin SO, Keum C, Woo J, et al: Successful weight reduction and maintenance by', 'using a smartphone application in those with overweight and obesity. Sci Rep 6:34563,', '2016', '28.', 'Toro-Ramos T, Lee DH, Kim Y, et al: Effectiveness of a Smartphone Application', 'for the Management of Metabolic Syndrome Components Focusing on Weight Loss: A', 'Preliminary Study. Metab Syndr Relat Disord 15:465-473, 2017', '29. Hamman RF, Wing RR, Edelstein SL, et al: Effect of weight loss with lifestyle', 'intervention on risk of diabetes. Diabetes Care 29:2102-7, 2006', '30.', 'Sepah SC, Jiang L, Peters AL: Translating the Diabetes Prevention Program into', 'an Online Social Network: Validation against CDC Standards. The Diabetes Educator', '40:435-443, 2014', '31.', 'Michaelides A, Raby C, Wood M, et al: Weight loss efficacy of a novel mobile', 'Diabetes Prevention Program delivery platform with human coaching. BMJ Open Diabetes', 'Research &amp; Care 4:e000264, 2016', '32. Alwashmi MF, Mugford G, Abu-Ashour W, et al: A Digital Diabetes Prevention', 'Program (Transform) for Adults With Prediabetes: Secondary Analysis. JMIR diabetes', '4:e13904-e13904,2 2019', '33.', 'Fried LP, Tangen CM, Walston J, et al: Frailty in older adults: evidence for a', 'phenotype. J Gerontol A Biol Sci Med Sci 56:M146-56, 2001', '34.', 'Ness KK, Kirkland JL, Gramatges MM, et al: Premature Physiologic Aging as', 'a', 'Paradigm for Understanding Increased Risk of Adverse Health Across the Lifespan of', 'Survivors of Childhood Cancer. J Clin Oncol 36:2206-2215, 2018', '35.', 'Campbell JM, Bellman SM, Stephenson MD, et al: Metformin reduces all-cause', 'mortality and diseases of ageing independent of its effect on diabetes control: A systematic', 'review and meta-analysis. Ageing Res Rev 40:31-44, 2017', \"St. Jude Children's Research Hospital\", 'Initial version, dated: 04-10-20', 'IRB approkB date', 'NUMBER: 20-0550', 'Protocol document date: 10-12-2020', 'IRB APPROVAL DATE: 11/10/2020']['PREDM', 'Page 52', '36.', 'Wang CP, Lorenzo C, Habib SL, et al: Differential effects of metformin on age', 'related comorbidities in older men with type 2 diabetes. J Diabetes Complications 31:679-', '686, 2017', '37.', 'Espinoza SE, Jiwani R, Wang J, et al: Review of Interventions for the Frailty', 'Syndrome and the Role of Metformin as a Potential Pharmacologic Agent for Frailty', 'Prevention. Clin Ther 41:376-386, 2019', '38.', 'Hudson MM, Ness KK, Nolan VG, et al: Prospective medical assessment of adults', 'surviving childhood cancer: study design, cohort characteristics, and feasibility of the St.', 'Jude Lifetime Cohort study. Pediatr Blood Cancer 56:825-36, 2011', '39.', 'Kalichman SC, Amaral CM, Cherry C, et al: Monitoring medication adherence by', 'unannounced pill counts conducted by telephone: reliability and criterion-related validity.', 'HIV clinical trials 9:298-308, 2008', '40.', 'Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes', '2018. Diabetes Care, 2018', '41.', 'Jackson AS, Pollock ML: Generalized equations for predicting body density of', 'men. Br J Nutr 40:497-504, 1978', '42.', 'Jackson AS, Pollock ML, Ward A: Generalized equations for predicting body', 'density of women. Med Sci Sports Exerc 12:175-81, 1980', '43.', 'Karlage RE, Wilson CL, Zhang N, et al: Validity of anthropometric measurements', 'for characterizing obesity among adult survivors of childhood cancer: A report from the St.', 'Jude Lifetime Cohort Study. Cancer 121:2036-43, 2015', '44.', 'Survey UDoHaHSNHaNE: US Department of Health and Human Services:', 'National Health and Nutrition Examination Survey. 2007-2008 Data Documentation,', 'Codebook, and Frequencies. Physical Activity (PAQ_E), 2009', '45.', 'Mathiowetz V, Kashman N, Volland G, et al: Grip and pinch strength: normative', 'data for adults. Arch Phys Med Rehabil 66:69-74, 1985', '46.', 'Mathiowetz V, Weber K, Volland G, et al: Reliability and validity of grip and', 'pinch strength evaluations. J Hand Surg Am 9:222-6, 1984', '47.', 'Ware JE, Jr., Sherbourne CD: The MOS 36-item short-form health survey (SF-36).', 'I. Conceptual framework and item selection. Med Care 30:473-83, 1992', '48. Kelly TL, Wilson KE, Heymsfield SB: Dual energy X-Ray absorptiometry body', 'composition reference values from NHANES. PLoS One 4:e7038, 2009', '49.', 'Eleftheriadou I, Tsioufis C, Tsiachris D, et al: Choice of antihypertensive', 'treatment in subjects with pre-diabetes. Is there a dream after the navigator. Curr Vasc', 'Pharmacol 9:715-22, 2011', '50.', 'Pakkir Maideen NM, Jumale A, Balasubramaniam R: Drug Interactions of', 'Metformin Involving Drug Transporter Proteins. Advanced pharmaceutical bulletin 7:501-', '505, 2017', '51.', 'Triplitt C: Drug Interactions of Medications Commonly Used in Diabetes.', 'Diabetes Spectrum 19:202-211, 2006', '52.', 'Zaidi FH, Kinnear PE: Acetazolamide, alternate carbonic anhydrase inhibitors and', 'hypoglycaemic agents: comparing enzymatic with diuresis induced metabolic acidosis', 'following intraocular surgery in diabetes. The British journal of ophthalmology 88:714-', '715, 2004', '53.', 'Ismail IS: The Role of Carbonic Anhydrase in Hepatic Glucose Production. Curr', 'Diabetes Rev 14:108-112, 2018', \"St. Jude Children's Research Hospital\", 'Initial version, dated: 04-10-20', 'IRB approkB date NUMBER: 00-00-00 20-0550', 'Protocol document date: 10-12-2020', 'IRB APPROVAL DATE: 11/10/2020']\n\n###\n\n", "completion": "END"}